Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 4, 2007

AstraZeneca Acquires Biologics Manufacturing Facility in Canada

  • AstraZeneca acquired a Montreal-based biologics manufacturing facility from DSM Biologics. The facility, occupying 66,000 sq. ft., will be used to manufacture antibody drug candidates for clinical trials and will serve the whole of the AstraZeneca group.

    Work to recommission the facility is expected to begin immediately, and the company plans to commence full scale production in 2009.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »